Sai Life Sciences’ ₹3,042 crore IPO opens today, closing December 13. The offer includes a fresh issue and an OFS, aiming to repay debt. Priced at ₹522-549 per share, analysts advise caution due to high valuation and OFS-heavy structure, despite strong financial performance.
Oil prices plummeted to their lowest levels since 2021 due to new U.S. tariffs announced by President Trump and increased output by OPEC+. Brent and
Jefferies’ Chris Wood criticizes Trump’s sweeping new tariffs, calling April 2 “an impoverishment day.” With steep levies on key Asian economies, analysts warn of global
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003